You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma

J. W. Smith, M. H. Shiu, L. Kelsey and M. F. Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Recent studies suggest an improved survival in patients who undergo radical lymph node dissection for the curative treatment of gastric carcinoma. We have undertaken a retrospective review to compare morbidity and mortality between patients who underwent radical lymph node dissection and those who underwent resections of lesser scope. Of the surgically related events compared, only the amount of postoperative abdominal drainage was significantly different in the group that underwent radical lymph node dissection Forty-four percent of patients who underwent radical lymph node dissection and 35% of patients who underwent a procedure of lesser scope developed a major complication. There was also no significant difference in the postoperative death rate, with a total of two 30-day in-hospital deaths (1.1%). Our observations indicate that radical lymph node dissection can be performed as safely as lesser operations for gastric carcinoma, and should not be avoided because of the fear of complications.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
Fujitani et al.
Ann. Surg. Oncol. 2007;14:2010-2017.
ABSTRACT | FULL TEXT  

Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
Fujitani et al.
Ann. Surg. Oncol. 2007;14:1305-1311.
ABSTRACT | FULL TEXT  

An Overseas Perspective of Evolving Gastric Cancer Practices in Japan
Li
Jpn J Clin Oncol 2005;35:165-167.
FULL TEXT  

Role of the Extended Lymphadenectomy in Gastric Cancer Surgery: Experience in a Single Institution
Sierra et al.
Ann. Surg. Oncol. 2003;10:219-226.
ABSTRACT | FULL TEXT  

Recurrence Patterns After Radical Gastrectomy for Gastric Cancer: Prognostic Factors and Implications for Postoperative Adjuvant Therapy
Schwarz and Zagala-Nevarez
Ann. Surg. Oncol. 2002;9:394-400.
ABSTRACT | FULL TEXT  

East is East and West was West: Closing the Gap in the Delivery of Gastric Cancer Surgery
Jpn J Clin Oncol 2001;31:469-470.
FULL TEXT  

Postoperative Adjuvant Chemoradiation Therapy for Patients With Resected Gastric Cancer: Intergroup 116
Schwarz and Kelsen
JCO 2001;19:1879-1880.
FULL TEXT  

Pancreas-Preserving Total Gastrectomy for Gastric Cancer
Doglietto et al.
Arch Surg 2000;135:89-92.
ABSTRACT | FULL TEXT  

Extended Lymph-Node Dissection for Gastric Cancer
Bonenkamp et al.
NEJM 1999;340:908-914.
ABSTRACT | FULL TEXT  

Lymph-Node Dissection for Gastric Cancer
Brennan
NEJM 1999;340:956-958.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.